Autoderm

Berkeley, United States and London, United Kingdom. European office in Barcelona, Spain and Gothenburg, Sweden.  All United Kingdom companies → Founded 2023
Developer Platform / API Specialty-Focused AI Telehealth Network
Accelerator — unknown

Products

Autoderm
Autoderm
Clinical Decision Support & Reference
Autoderm is an AI-powered API that provides pre-triage and informational condition suggestions for teledermatology platforms, aiming to improve efficiency and case quality.

See all 1 product →

About Autoderm

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic healthcare records, blogs, websites, and mobile applications. The intended use of Autoderm’s technology is as a decision support tool for healthcare providers and a triage/informational tool for laypersons. It aims to provide clinically validated, skin-tone inclusive dermatology support, addressing the global shortage of dermatologists and improving access to skin health information.

For physicians, Autoderm’s API acts as an AI-powered dermatology analytics engine that offers decision support and helps identify clinical workflows. It processes still images and returns probabilistic predictions for over 70 dermatological conditions across six clinical categories, along with confidence scores and recommended care pathways. The output is designed to be reviewed by a clinician before any clinical decision is made. Studies have shown that AI-assisted GPs achieved higher accuracy in skin lesion diagnosis and reduced dermatology referrals. Autoderm’s technology is developed with strict adherence to European and international requirements for safe, privacy-preserving AI in healthcare, is CE-marked (MDD Class I legacy, MDR Class IIa in progress), and holds FDA Breakthrough Device Designation. The company emphasizes that its AI is designed to support clinicians, not replace them, by providing specialist pattern recognition in settings where access to dermatologists is limited.

Beyond disease detection, the API also offers Fitzpatrick skin-type classification, a blur/image-quality screen, a genitalia content-safety classifier, and an age estimator. Autoderm’s API is fully white-label, allowing healthcare platforms to integrate the technology seamlessly under their own branding and user experience. The company also recruits doctors, residents, and medical students as Clinical Reviewers to read real skin images and provide their judgment, which serves as the reference standard for the AI’s learning.

Focus Areas

AI-powered dermatology skin disease screening clinical decision support teledermatology virtual primary care pharmacy solutions healthcare analytics medical devices

Business Intelligence

Key InvestorsAlmirall (strategic partner)
PartnershipsLablab NEXT AI Accelerator program, Boots UK, DocMorris Germany, iPlato (myGP app - concluded June 2026)
Acquisitionsunknown
TechnologyAI-powered dermatology analytics API, deep convoluted neural network, cloud-native (EU-hosted infrastructure)
FDA Clearances0 (FDA Breakthrough Device Designation, clearance pending) cleared products (estimated)

What Physicians Need to Know

AI-Powered Dermatology Decision Support
Autoderm offers an AI-powered dermatology decision support API that analyzes smartphone images to screen for over 70 skin conditions, returning results in under 1 second. This tool is intended to enhance decision-making and diagnoses in clinical workflows for healthcare professionals.
Extensive Clinical Evidence & Regulatory Compliance
Autoderm has a robust clinical evidence portfolio, including five peer-reviewed publications across five countries and over 3 million API calls since 2018 with zero adverse events. It is a CE-marked medical device (MDD Class I, transitioning to MDR Class IIa) and has received FDA Breakthrough Device Designation.
White-Label & Developer-Friendly API
The Autoderm API is fully white-label, allowing platforms to retain complete control over branding, UI, wording, and the patient journey. It features a clear REST API, comprehensive documentation, and SDKs designed for easy integration into existing healthcare stacks.
Bias Evaluation Across Skin Tones
Autoderm has conducted Fitzpatrick17K bias evaluation across 26 conditions and Fitzpatrick Skin Types Iu2013VI, reporting no systemic bias detected.
Reduced Referrals and Improved Efficiency
Studies have shown that AI-assisted GPs using Autoderm achieved higher top-1 accuracy (69% vs. 48% without AI) and reduced dermatology referrals by 40%. The tool also significantly reduces the time spent on diagnosis and management.
Broad Application Across Healthcare Settings
Autoderm's API is designed for integration into various platforms, including primary care, online pharmacies, teledermatology platforms, and consumer wellness apps.
Physician Tip

For physicians, Autoderm acts as a powerful clinical decision support tool, not a replacement for diagnosis. It provides a ranked list of possible skin conditions with confidence scores, helping to enhance decision-making and streamline clinical workflows. The AI-assisted approach has been shown to consistently outperform clinicians working without AI assistance, reducing referrals and improving diagnostic accuracy. The system is designed to provide informational suggestions and context, allowing the physician to make the final clinical decision and define the care pathway.

Autoderm offers a developer-friendly REST API with comprehensive documentation and SDKs, enabling seamless integration into various healthcare platforms and workflows, including electronic healthcare records, telemedicine apps, and pharmacy systems. The API is fully white-label, ensuring that the integrating platform maintains its branding.

Products by Autoderm

1 product in the directory

Autoderm
Autoderm
Clinical Decision Support & Reference
Autoderm is an AI-powered API that provides pre-triage and informational condition suggestions for teledermatology platforms, aiming to improve efficiency and case quality.

Reviews & Opinions

No web reviews on file yet for Autoderm. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Autoderm.

Loading videos...

Videos load interactively. If none appear, search YouTube for Autoderm →

View all on YouTube

Press & Coverage

Autoderm
AUTODERM joins Lablab NEXT AI accelerator program, leading the future of AI-driven dermatology
AUTODERM announced its participation in the Lablab NEXT AI Accelerator program, aiming to revolutionize skin disease screening through AI-driven dermatologic analytics and make advanced diagnostic support widely accessible. The program, kicking off on August 26, will help AUTODERM expand its innovative solutions globally.
2024-07
Autoderm
Autoderm's AI and the myGP app by iPlato revolutionize skin health
Autoderm's AI-powered skin scanner was a key feature in the myGP app by iPlato, screening over 370,000 skin images and identifying approximately 5% of UK melanoma cases. The technology aimed to triage skin conditions efficiently and accurately, guiding patients to appropriate care.
2024-06
Autoderm
Autoderm AI has flagged an estimated 5% of UK melanoma cases for clinical review
In May 2024, Autoderm's AI analyzed 18,359 skin ailments through the myGP app, flagging 80 possible melanomas, 95 squamous cell carcinomas, and 202 basal cell carcinomas. This post-market clinical follow-up demonstrated the AI's role in early detection, identifying about 5% of UK melanoma cases monthly.
2024-06
Autoderm
Teledermatology Platforms and AI-Assisted Pre-Triage
Autoderm's API integrates into teledermatology platforms to assist with pre-triage, processing uploaded images and providing informational condition suggestions with confidence levels. A 2023 study found that AI-assisted triage led to a 34% reduction in specialist referrals and 100% melanoma detection sensitivity.
2026-05
Autoderm
Are mass population screenings for skin diseases cost effective?
This article discusses the cost-effectiveness of mass population screenings for skin diseases using AI, highlighting that 20% of GP visits are skin-related. Autoderm's screenings in May 2024 suggested that 50% of cases could be triaged for self-care, potentially saving the NHS significant costs.
2026-05
Autoderm
AI in virtual primary care: how digital front-door platforms use skin analysis
Autoderm's medical-grade AI provides informational image analysis for digital health platforms, supporting user awareness of potential skin concerns and guiding them to appropriate next steps. A study showed 92% of GPs found the AI useful, and it could avoid 34% of specialist referrals.
2026-04
Autoderm
Regulatory compliance - Autoderm
Autoderm is CE-marked as a Class I Medical Device under EU MDD 93/42/EEC and is transitioning to MDR Class IIa. It also holds FDA Breakthrough Device Designation for AI-powered dermatology screening and is registered with the MHRA in the UK.
unknown
First Derm
Almirall Backs Autoderm In The AI Technology Race - Online Dermatology - First Derm
Almirall has backed Autoderm in developing its AI technology, aiming to advance healthcare technology and secure its place in the digital health market. Autoderm, the advanced technology arm of First Derm, utilizes a vast database and dermatologist verification to provide accurate results for 43 skin diseases.
2019-11

Frequently Asked Questions

Autoderm's AI solution is designed for seamless integration with current electronic health records (EHRs) and practice management systems. It assists physicians in early skin disease screening by analyzing dermatoscopic images and providing evidence-based clinical decision support, flagging suspicious lesions and offering differential diagnoses to enhance diagnostic accuracy and efficiency.
Autoderm's AI is trained on a vast dataset of dermatological images to screen for a wide range of skin conditions, including melanoma, basal cell carcinoma, squamous cell carcinoma, and various benign lesions. Studies indicate its accuracy is comparable to, and in some cases surpasses, that of general practitioners in identifying suspicious lesions, aiding in earlier detection and referral.
Autoderm extends its support to virtual primary care and teledermatology by enabling remote consultations and specialist referrals, improving access to care in underserved areas. For pharmacy solutions, it can integrate with e-prescribing systems to streamline medication management. Healthcare administrators benefit from increased operational efficiency, reduced patient wait times, and enhanced patient satisfaction through these integrated services.
Autoderm's primary product is its AI-powered diagnostic software, often coupled with specialized dermatoscopes for high-resolution image capture. The company adheres strictly to global medical device regulations, including FDA clearance and CE marking, and maintains robust data privacy protocols compliant with HIPAA, GDPR, and other relevant regulations to protect patient information.
Autoderm offers flexible pricing models, including subscription-based services, tailored to the size and needs of the healthcare practice. Comprehensive support for physicians includes training, technical assistance, and ongoing clinical updates. Autoderm is committed to long-term stability, actively seeking partnerships with healthcare providers, academic institutions, and technology companies to expand its reach and continuously innovate its solutions.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AllergoGPT is an evidence-based AI operating system that serves as the “brain” behind the allergoSMART ecosystem, focusing on allergology. It integrates diverse data sources such as botany, weather, nutrition, medical guidelines, clinical experience, and real-world patient behavior to provide transparent and valid insights for patients, physicians, and researchers. The system is designed to structure data, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.